1235 terminated. 1235 Phase 2, 253 Phase 1, 79 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1235 | Terminated 1235 |
| Phase 1 | 253 | Terminated 253 |
| Phase 3 | 79 | Terminated 79 |
Follow Urogenital Diseases: new trials by email Literature Review of Urogenital Diseases trials Research Report on Urogenital Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Engineered Immune Effectors Against Ovarian Cancer OC-CTLs - Ovarian Cancer | Phase 1 / Phase 2 | Terminated | Shenzhen Geno-Immune Medical Institute | 20 | 2026-06-01 | 2026-08-24 |
| Intervention of CAR-T Against Cervical Cancer Cervical cancer-specific CAR-T cells - Cervical Cancer | Phase 1 / Phase 2 | Terminated | Shenzhen Geno-Immune Medical Institute | 20 | 2026-06-01 | 2026-08-24 |
| Engineered Immune Effectors Against Cervical Cancer CC-EIEs - Cervical Cancer | Phase 1 / Phase 2 | Terminated | Shenzhen Geno-Immune Medical Institute | 20 | 2026-06-01 | 2026-08-24 |
| Intervention of Bladder Cancer by CAR-T 4SCAR-PSMA, 4SCAR-FRa - Bladder Cancer, Urothelial Carcinoma Bladder | Phase 1 / Phase 2 | Terminated | Shenzhen Geno-Immune Medical Institute | 20 | 2025-08-01 | 2026-08-24 |
| Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis) Vonafexor low dose, Vonafexor high dose - Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3 | Phase 2 | Terminated | Enyo Pharma | 10 | 2025-07-01 | 2026-04-23 |
| A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer Abemaciclib, Biopsy, Bone Scan - Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm | Phase 2 | Terminated | OHSU Knight Cancer Institute | 6 | 2025-06-24 | 2026-04-28 |
| Genetically Modified T Cells Against Ovarian Cancer OC-IgT cells - Ovarian Cancer | Phase 1 / Phase 2 | Terminated | Shenzhen Geno-Immune Medical Institute | 100 | 2025-05-01 | 2026-08-24 |
| A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE) GDC-8264, Placebo - Acute Kidney Injury | Phase 2 | Terminated | Genentech, Inc. | 67 | 2025-01-17 | 2026-03-16 |
| Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT Finerenone (BAY 94-8862), Empagliflozin 10 mg - Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC) | Phase 2 | Terminated | Jinling Hospital, China | 10 | 2025-01-01 | 2025-12-11 |
| A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers AUR109 200mg, AUR109 300mg, AUR109 400mg - Ovarian Cancer, Colorectal Cancer | Phase 2 | Terminated | Aurigene Discovery Technologies Limited | 29 | 2024-11-09 | 2026-04-17 |
| A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma Temferon, Pembrolizumab, Cabozantinib - Clear Cell RCC | Phase 1 / Phase 2 | Terminated | Genenta Science | 10 | 2024-10-22 | 2026-02-09 |
| A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer CBX-12 - Platinum-resistant Ovarian Cancer, Refractory Ovarian Carcinoma | Phase 2 | Terminated | Cybrexa Therapeutics | 40 | 2024-09-25 | 2026-08-20 |
| Bone in CKD Alkali Response (BICARb Pilot Trial) Potassium Citrate Extended Release Oral Tablet, Placebo, Potassium Citrate and Citric Acid Oral Solution - Chronic Kidney Diseases, Bone Loss | Phase 2 / Phase 3 | Terminated | Albert Einstein College of Medicine | 6 | 2024-08-15 | 2026-07-28 |
| A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk" Auxora, Placebo - Acute Kidney Injury | Phase 2 | Terminated | CalciMedica, Inc. | 122 | 2024-07-01 | 2026-08-31 |
| Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy Promitil - Cancer of Ovary, Pancreatic Ductal Adenocarcinoma | Phase 2 | Terminated | Lipomedix Pharmaceuticals Inc. | 19 | 2024-06-13 | 2026-01-09 |
| Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study Apalutamide, Biopsy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Terminated | University of Washington | 8 | 2024-05-23 | 2026-10-19 |
| Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction Targeted Microwave Ablation - Benign Prostatic Hyperplasia | Phase 2 | Terminated | Assistance Publique - Hôpitaux de Paris | 8 | 2024-04-24 | 2026-10-01 |
| A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors INCB099280, axitinib - Advanced Solid Tumors | Phase 1 / Phase 2 | Terminated | Incyte Corporation | 5 | 2024-04-16 | 2026-06-04 |
| BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer carboplatin, Paclitaxel, Recombinant humanized anti-PD-1 monoclonal antibody injection - Endometrial Cancer | Phase 2 / Phase 3 | Terminated | Bio-Thera Solutions | 5 | 2024-04-09 | 2025-08-14 |
| CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations Abiraterone Acetate/Niraparib, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Terminated | Mayo Clinic | 8 | 2024-03-05 | 2026-07-22 |
Showing 20 of 1235. Sign in to see all of them.
Prostatic Neoplasms (281) · Ovarian Neoplasms (188) · Carcinoma, Renal Cell (145) · Urinary Bladder Neoplasms (92) · HIV Infections (76) · Neoplasm Metastasis (76) · Uterine Cervical Neoplasms (63) · Kidney Neoplasms (61) · Neoplasms (59) · Carcinoma, Ovarian Epithelial (58) · Fallopian Tube Neoplasms (58) · Carcinoma, Non-Small-Cell Lung (47) · Endometrial Neoplasms (45) · Breast Neoplasms (43) · Melanoma (40)
Female Urogenital Diseases and Pregnancy Complications (839) · Neoplasms by Site (810) · Urogenital Neoplasms (803) · Female Urogenital Diseases (796) · Male Urogenital Diseases (789) · Neoplasms (781) · Genital Diseases (746) · Urologic Diseases (460) · Genital Diseases, Female (340) · Kidney Diseases (318) · Genital Diseases, Male (317) · Neoplasms by Histologic Type (315) · Genital Neoplasms, Female (295) · Genital Neoplasms, Male (293)
Paclitaxel (51) · Docetaxel (50) · Carboplatin (46) · Gemcitabine (43) · pembrolizumab (36) · Cisplatin (32) · Nivolumab (32) · Bevacizumab (28) · Prednisone (27) · Cyclophosphamide (25) · Sunitinib (22) · Everolimus (19) · Interleukin-2 (19) · Sorafenib (18) · Saline Solution (15)
National Cancer Institute (NCI) (57) · M.D. Anderson Cancer Center (34) · Gynecologic Oncology Group (15) · National Institute of Allergy and Infectious Diseases (NIAID) (13) · Novartis Pharmaceuticals (13) · Pfizer (12) · University of Wisconsin, Madison (12) · Merck Sharp & Dohme LLC (11) · Stanford University (10) · University of Washington (10) · Bristol-Myers Squibb (9) · Dana-Farber Cancer Institute (9) · Medical University of South Carolina (9) · University of California, San Francisco (9) · ViiV Healthcare (9)
United States (888) · Canada (120) · France (106) · Spain (96) · United Kingdom (91) · Germany (80) · Italy (79) · Australia (48) · Belgium (48) · Poland (48) · Netherlands (45) · China (41) · South Korea (36) · Czechia (30) · Taiwan (29)
Robert J Amato, DO (8) · Steven A Rosenberg, M.D. (7) · Stanislaw R. Burzynski, MD, PhD (6) · Alp Ikizler, MD (5)
PMID 37528520, PMID 38299639, PMID 32734597, PMID 37185961, PMID 39356039, PMID 29282009, PMID 32390133, PMID 32897402, PMID 36791280, PMID 39382091, PMID 10467792, PMID 10548619, PMID 10908457, PMID 11224527, PMID 11502292, PMID 12586591, PMID 12713990, PMID 12826431, PMID 14534883, PMID 14600674, PMID 14615449, PMID 15014939, PMID 15155205, PMID 15199325, PMID 15240681, PMID 15589587, PMID 15721430, PMID 15791633, PMID 15864277, PMID 15954876, PMID 16271750, PMID 16325893, PMID 16382236, PMID 16400639, PMID 16478630, PMID 16581405, PMID 16673051, PMID 16842791, PMID 16962381, PMID 17018256, PMID 17105988, PMID 17197859, PMID 17634155, PMID 17919105, PMID 17949799, PMID 18230259, PMID 18343810, PMID 18416737, PMID 18568488, PMID 18586928
2017 (18), 2016 (13), P30CA072720 (11), 2018 (10), 2009 (8), 2019 (7), 2023 (7), 2008 (6), P30CA016672 (6), 2005 (5), P30CA015704 (5), U10CA032102 (5), 2014 (4), U01AI068636 (4), 2015 (3)